Summary
This large-scale epigenome-wide association study identified DNA methylation signatures associated with body mass index and adverse outcomes of adiposity across multiple European and international cohorts. Published in Nature (2016), the research represents a collaborative effort involving dozens of research groups and suggests that epigenetic modifications may serve as biomarkers for obesity-related health risks. The findings contribute to understanding the molecular mechanisms linking adiposity to chronic disease.
UK applicability
The study's multi-cohort design likely includes UK-based participants and cohorts, making findings potentially applicable to UK populations. The identified epigenetic biomarkers could inform future UK public health surveillance and personalised risk assessment strategies for obesity-related diseases.
Key measures
DNA methylation at CpG sites; body mass index; epigenetic biomarkers associated with adiposity and related adverse health outcomes
Outcomes reported
The study conducted an epigenome-wide association study (EWAS) to identify DNA methylation patterns associated with body mass index and adverse health outcomes related to adiposity. The research examined epigenetic markers across multiple cohorts to establish associations between methylation status and obesity-related phenotypes.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.